Media conditioned by human leukemic T-cells induce expression of IL2 receptors and proliferation of normal T lymphocytes
Constantinos Kosmatopoulos
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorMichèle Allouche
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorFrédéric Triebel
Laboratoire d'Immunologie Néphrologique et de Transplantation, U.E.R. de la Pitié, Boulevard de l'Hǒpital, 75013 Paris, France
Search for more papers by this authorMaria Zanti
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorCorine Clemenceau
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorJean-Claude Gluckman
Laboratoire d'Immunologie Néphrologique et de Transplantation, U.E.R. de la Pitié, Boulevard de l'Hǒpital, 75013 Paris, France
Search for more papers by this authorClaude Jasmin
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorCorresponding Author
Vassilis Georgoulias
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, FranceSearch for more papers by this authorConstantinos Kosmatopoulos
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorMichèle Allouche
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorFrédéric Triebel
Laboratoire d'Immunologie Néphrologique et de Transplantation, U.E.R. de la Pitié, Boulevard de l'Hǒpital, 75013 Paris, France
Search for more papers by this authorMaria Zanti
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorCorine Clemenceau
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorJean-Claude Gluckman
Laboratoire d'Immunologie Néphrologique et de Transplantation, U.E.R. de la Pitié, Boulevard de l'Hǒpital, 75013 Paris, France
Search for more papers by this authorClaude Jasmin
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Search for more papers by this authorCorresponding Author
Vassilis Georgoulias
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, France
Unité d'Oncogénèse Appliquée, INSERM U 268, Hǒpital Paul Brousse, 14–16 Av. Paul Vaillant Couturier, 94800 Villejuif, FranceSearch for more papers by this authorAbstract
Peripheral blood T-colony-forming cells (T-CFC) from patients with T-cell acute lymphoblastic leukemias (T-ALL) and T-cell non-Hodgkin lymphomas (T-NHL) can generate colonies in methylcellulose in the absence of added growth factors and/or mitogenic stimulation. In the present study, we show that media conditioned (LCM) by unstimulated mononuclear cells (MNC) from these patients can induce proliferation (proliferating inducing activity; PIA) and promote colony growth (T-cell colony promoting activity; T-CPA) of normal T lymphocytes in the absence of any other mitogenic stimulation. Preincubation of normal E+ lymphocytes with some TCPA+, PIA−-LCM for 48 hr leads to IL2-induced cell proliferation in the absence of any other stimulation. Moreover, staining of the cells with anti-Tac monoclonal antibody (Mab) reveal 9%-26% Tac+ cells. Both PIA and IL2 receptor-inducing activities were abrogated by treatment of LCM with proteolytic enzymes or by heating at 47°C for 30 min. Modulation of the T3 molecule by OKT3 MAb on normal E+ cells did not abrogate the capacity of LCM to induce expression of IL2-receptors, suggesting that this activity was not mediated by triggering the Ti-T3 molecular complex. These activities were detected in media conditioned by both unfractionated MNC and blast-enriched cell fractions, and their production required DNA and RNA synthesis by actively dividing cells. Taken together, these findings indicate that human leukemic T cells spontaneously release activites which can activate normal resting T lymphocytes.
References
- Bertoglio, J., Boisson, N., Bonnet, M. C., Chatenoud, L., Chouaib, S., Degiovanni, G., Fradelizi, D., Godard, A., Goube de Laforest, P., Harel-Bellan, A., Jacubovich, R., Lacaze, M., Lahaye, T., Mossalayi, M., Pla, M., Rey, A., Rothschild, E., Schmitt C., Serrou, B., Soulillou, J. P., Triebel, F., Ythier, A., First French Workshop on standardization of human IL2. A joint report. Lymphokine Res., 1, 121–127 (1982).
- Buick, R. N., Messner, H. A., Till, J. E., and McCulloch, E. A., Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. J. nat. Cancer Inst., 62, 249–254 (1979).
- Cantrell, D. A., and Smith, K. A., The Interleukin-2 T-cell system: A new cell growth model. Science, 224, 1312–1316 (1984).
- Claesson, M. H., Rodger, H. D., Johnson, G. R., Wittingham, S., and Metcalf, D., Colony formation by human lymphocytes in agar medium. Clin. exp. Immunol., 28, 526–534 (1977).
- Georgoulias, V., Allouche, M., and Jasmin, C., Regulation of T-cell colony formation in the absence of added growth factors in patients with T-cell malignancies. In: F. Cavalli (ed.), Proc. 2nd Int. Conference on Malignant Lymphoma: Current status and prospects, Nijhoff, Boston, in press (1984a).
- Georgoulias, V., Auclair, H., and Jasmin, C., Heterogeneity of peripheral blood T colony-forming cells of patients with T-cell malignancies. Leukemia Res., 8, 1025–1036 (1984b).
- Georgoulias, V., Bourinbaiar, A., Amesland, F., Canon, C., Auclair, H., and Jasmin, C., Colony formation in the absence of added growth factors by peripheral blood T colony-forming cells of patients with T-cell malignancies. Int. J. Cancer, 34, 471–477 (1984c).
- Georgoulias, V., Marion, S., Consolini, R., and Jasmin, C., Characterization of normal peripheral blood T and B-cell colony-forming cells: Growth factor(s) and accessory cell requirements for their in vitro proliferation. Cell. Immunol., 95, 1–13 (1985a).
- Georgoulias, V., Triebel, F., Kosmatopoulos, C., Allouche, M., Gluckman, J. C., and Jasmin, C., T-cell colony growth in patients with T-cell malignancies: Growth factor requirements for in vitro proliferation of peripheral blood T-colony forming cells (T-CFC). Leukemia Res., in press (1985b).
- Georgoulias, V., Allouche, M., Kosmatopoulos, C., Jasmin, C., Study of the T-cell colony-forming cell (T-CFC) proliferation in patients with T-cell malignancies. In ‘ Leukemia: Recent advances in Biology and Treatment’, UCLA Symposia, Alan R. Liss, Inc., New York, in press (1985c).
- Gillis, S., Interleukin 2: biology and biochemistry. J. clin. Immunol., 3, 1–13 (1983).
- Gootenberg, J. E., Ruscetti, F. N., Mier, J. W., Gazdar, A., and Gallo., R. C., Human cutaneous T-cell lymphoma and leukemia cell lines produce and respond to T-cell growth factor. J. exp. Med., 154, 1403–1418 (1981).
- Gordon, J., and McLean, L., A lymphocyte-stimulating factor produced in vitro. Nature (Lond.), 208, 795–796 (1965).
- Hays, E. F., Goodrum, D., Bessho, M., Kitada, S., and Uittenbogaart, C. H., Leukemia-derived growth factor (non-Inter-leukin 2) produced by murine lymphoma T-cell lines. Proc. nat. Acad. Sci. (Wash.), 81, 7807–7813 (1984).
- Kasakura, S., and Lowenstein, L., A factor stimulating DNA synthesis derived from the medium of leucocyte culture. Nature, 208, 794–795 (1965).
- Kasakura, S., Taguchi, M., Watanaba, Y., Okubo, T., Murachi, T., Uchino, H., and Hanaska, M., A mitogenic factor, released by stimulated human mononuclear cells and distinct from Interleukin 2 (IL2), B cell growth factor (BCGF), and Interleukin 1 (IL1). J. Immunol., 133, 3084–3090 (1984).
- Lachman, L., Hacker, M. P., and Handsdrualher, E. R., Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques. J. Immunol., 119, 2109–2114 (1977).
- Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., and Greene, W. C., A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (Lond.), 300, 267–269 (1982).
- Lipkovitz, S., Greene, W. C., Rubin, A. L., Novogrodsky, A., and Stenzel, K. H., Expression of receptors for Interleukin 2: role in the commitment of T lymphocytes to proliferate. J. Immunol., 132, 3137 (1984).
- Maosen, M., and Johnson, H. E., A methodological study of Erosette formation using AET-treated sheep red blood cells. J. immunol. Meth., 27, 61–67 (1979).
- Meuer, S. C., Hussey, R. E., Cantrell, D. A., Hodgdon, J. C., Schlossman, S. F., Smith, K. A., and Reinherz, E. L., Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an Interleukin 2-dependent autocrine pathway. Proc. nat. Acad. Sci. (Wash.), 81, 1509–1513 (1984a).
- Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. F., Schlossman, S. F., and Reinherz, E. L., An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell, 36, 897–906 (1984b).
- Poiesz, B. J., Ruscetti, F. W., Mier, J. W., Woods, A. M., and Gallo, R. C., T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc. nat. Acad. Sci. (Wash.), 77, 6815–6819 (1980).
- Popovic, M., Lange-Wantzin, G., Sarin, P. S., Mann, D., and Gallo, R. C., Transformation of human umbilical cord blood T-cell by human T-cell leukemia/lymphoma virus. Proc. nat. Acad. Sci. (Wash.), 80, 5402–5406 (1983).
- Raulet, D. H., Expression and function of Interleukin 2 receptors on immature thymocytes. Nature (Lond.), 314, 101–103 (1985).
- Reinherz, E. L., A molecular basis for thymic selection: regulation of T11 induced thymocyte expansion by the T3-Ti antigen/MHC receptor pathway. Immunol. Today, 6, 75–79 (1985).
- Reinherz, E. L., and Schlossman, S. F., The differentiation of human T lymphocytes. Cell, 10, 821–827 (1980).
- Rinnooy, E. A., Platzer, E., Welke, K., and Wang, C. I., Modulation induction of the T3 antigen by OKT3 antibody is monocyte dependent. J. Immunol., 133, 2979–2985 (1984).
- Robb, R. J., Greene, W. C., and Rusk, C. H., Low and high affinity cellular receptors for Interleukin 2. Implications for the level of Tac antigen. J. exp. Med., 160, 1126–1146 (1984).
- Robb, R. J., Munck, A., and Smith, K. A., T-cell growth factor receptors. Quantitation, specificity and biological relevance. J. exp. Med., 154, 1455–1474 (1981).
- Rozenszajn, L. A., Shoham, D., and Kalechman, I., Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture. Immunology, 29, 1041–1055 (1975).
- Stojic-Grujicic, S., and Simic, M. M., Modulation of Interleukin 1 production by activated macrophages: in vitro action of hydrocortisone, colchicine and cytochalasin B. Cell. Immunol., 69, 235–247 (1982).
- Triebel, F., Gluckman, J. C., Debré, P., and Charron, D. J., Prethymic lymphoid progenitors in man. II. Biochemical characterization of a growth factor close to or similar to Interleukin 2 (IL2). Immunology, 53, 651–659 (1984).
- Triebel, F., Robinson, W. A., Hayward, A. R., and Goube de Laforest, P., Characterization of T lymphocyte colony-forming cells and evidence for the acquisition of T-cell makers in the absence of the thymic microenvironment in man. J. Immunol., 126, 2020–2034 (1981).
- Uchiyama, T., Broders, S., and Waldmann, T. A., A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol., 126, 1393–1397 (1981a).
- Uchiyama, T., Nelson, D. L., Fleisher, T. A., and Waldmann, T. A., A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic/killer T cells, suppressor cells on one of two types of helper T cells. J. Immunol., 126, 1398–1403 (1981b).
- Uittenbogaart, C. H., and Fahey, J. L., Leukemia-derived growth factor (non-Interleukin 2) produced by a human malignant T lymphoid cell line. Proc. nat. Acad. Sci. (Wash.), 79, 7004–7008 (1982).
- Von Boehmer, H., Grisanti, A., Kisielow, P., and Haas, W., Absence of growth by most receptor expressing fetal thymocytes in the presence of Interleukin 2. Nature (Lond.), 314, 539–541 (1985).
- Yodoi, J., Teshigawara, K., Nikaido, T., Fukui, K., Noma, T., Honjo, T., Takigawa, M., Sasaki, M., Minato, N., Tsudo, M., Uchiyama, T., and Maeda, M., TCGF (IL2)-receptor inducing factor(s): I. Regulation of IL2 receptor on a natural killer-like cell line (YT cells). J. Immunol., 134, 1623–1630 (1985).
- Yodoi, J., Teshigawara, K., Uchiyama, T., Wano, Y., Tsudo, H., Nikaido, T., Smith, K. A., and Maeda, M., Adult T-cell leukemia-derived factor augmenting TCGF (IL2) receptor expression. In: R. C. Gallo, M. Essex and L. Gross (eds.), Human T-cell leukemia-lymphoma viruses, pp. 255–260, Cold Spring Harbor Laboratory. New York (1984).